KRISTIAN JOHNSTON: Open Payments
NPI 1962891499 · TAMARAC, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,840 in 151 payments from 18 companies in 2025. Trend: 2023 $3,298 · 2024 $3,208 · 2025 $10,840
Speaker / faculty: $7,038Food & beverage: $3,662Education: $113Travel & lodging: $28
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 30 | $5,899 |
| Janssen Biotech, Inc. | 18 | $2,426 |
| ABBVIE INC. | 34 | $791 |
| Novartis Pharmaceuticals Corporation | 13 | $321 |
| Incyte Corporation | 5 | $246 |
| UCB, Inc. | 9 | $228 |
| Regeneron Healthcare Solutions, Inc. | 10 | $170 |
| GENZYME CORPORATION | 5 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $107 |
| Arcutis Biotherapeutics, Inc. | 5 | $98 |
Products named: NEMLUVIO, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, Opzelura, Bimzelx, SPEVIGO.
Industry payments across FL — which companies pay providers there.
